The therapy delivered by the HeartStart FR2+ is the most proven in the industry. More than 40 studies confirm its effectiveness. Philips’ high-current/low energy therapy ensures a potent defibrillation dose, while at the same time, minimizing side effects that may be harmful to a fragile heart. So the HeartStart FR2+ can deliver its most powerful therapy from the very first shock. There’s no need to hold back.

Capabilities and Features:

• Automated defibrillation, with manual override (ECG model only)
• SMART Analysis
• SMART CPR and Quick Shock
• Infant/child defibrillation
• Conscious monitoring with optional FR2+ ECG Assessment Module
• Optional rechargeable battery
• Two display options: text-only, and text with ECG
• Voice and text prompts
• Over 8 hours of data collection
• Programmable voice recording
• Automated self-tests
• "Ready-for-Use" indicator
• Long-life battery: 300 shocks (minimum) or 12 hours monitoring
• Pads can connect to most ALS defibrillator/monitors via pads adapters